Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 11, 2008Clinical Endocrinology

Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor‐21 in patients with type 2 diabetes and obesity

View Full Paper
Ask AI
Bookmark
Share

Authors

MMMiloš MrázCharles UniversityMBMarkéta BártlováCharles UniversityZLZ LacinováCharles University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mráz et al. (2008) studied this question.

synapsesocial.com/papers/6aa2cfb23c35dfb37e2076e0https://doi.org/10.1111/j.1365-2265.2008.03502.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Plasma Concentrations of Fibroblast Growth Factors 19 and 21 in Patients with Anorexia Nervosa2008 · 111 citations
  2. 2Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin2002 · 579 citations
  3. 3Circulating FGF-21 Levels in Normal Subjects and in Newly Diagnose Patients with Type 2 Diabetes Mellitus2007 · 186 citations
  4. 4Adiponectin – journey from an adipocyte secretory protein to biomarker of the metabolic syndrome2005 · 770 citations
  5. 5Enhanced anti-apoptosis and gut epithelium protection function of acidic fibroblast growth factor after cancelling of its mitogenic activity2004 · 40 citations